Glenn A. Eisenberg
Net Worth

Last updated:

What is Glenn A. Eisenberg net worth?

The estimated net worth of Mr. Glenn A. Eisenberg is at least $63,757,888 as of 2 Dec 2024. He owns shares worth $8,628,880 as insider, has earned $35,329,008 from insider trading and has received compensation worth at least $19,800,000 in Laboratory Corporation of America Holdings.

What is the salary of Glenn A. Eisenberg?

Mr. Glenn A. Eisenberg salary is $1,980,000 per year as Chief Financial Officer & Executive Vice President in Laboratory Corporation of America Holdings.

How old is Glenn A. Eisenberg?

Mr. Glenn A. Eisenberg is 64 years old, born in 1961.

What stocks does Glenn A. Eisenberg currently own?

As insider, Mr. Glenn A. Eisenberg owns shares in one company:

Company Title Shares Price per share Total value
Laboratory Corporation of America Holdings (LH) Chief Financial Officer & Executive Vice President 31,289 $275.78 $8,628,880

What does Laboratory Corporation of America Holdings do?

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

LH logo
LH
Laboratory Corporation of America Holdings
$275.78

Glenn A. Eisenberg insider trading

Laboratory Corporation of America Holdings

Mr. Glenn A. Eisenberg has made 22 insider trades between 2015-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 20,033 units of LH stock on 27 Mar 2024. As of 2 Dec 2024 he still owns at least 31,289 units of LH stock.

Transaction Date Security Shares Price per share Total value Source
Option
Non-qualified Stock Options 8,923 $209.25 $1,867,138
Option
Non-qualified Stock Options 2,788 $221.67 $618,016
Sale
Common Stock 11,711 $240.43 $2,815,652
Option
Common Stock 8,923 $209.25 $1,867,138
Option
Common Stock 2,788 $221.67 $618,016
Sale
Common Stock 9,071 $224.55 $2,036,884
Sale
Common Stock 2,979 $222.65 $663,271
Sale
Common Stock 2,950 $223.62 $659,670
Option
Common Stock 10,229 N/A N/A
Option
Performance Share Unit 10,229 N/A N/A
Option
Restricted Stock Unit 10,229 N/A N/A
Option
Common Stock 10,229 N/A N/A
Option
Common Stock 20,033 N/A N/A
Option
Restricted Stock Unit 20,033 N/A N/A
Sale
Common Stock 6,665 $217.52 $1,449,777
Sale
Common Stock 18,379 $215.37 $3,958,212
Sale
Common Stock 7,907 $215.68 $1,705,350
Option
Non-qualified Stock Options 14,054 $163.63 $2,299,656
Option
Common Stock 14,054 $163.63 $2,299,656
Sale
Common Stock 1,553 $217.98 $338,529
Option
Common Stock 807 N/A N/A
Option
Restricted Stock Unit 807 N/A N/A
Option
Restricted Stock Unit 885 N/A N/A
Option
Common Stock 885 N/A N/A
Option
Restricted Stock Unit 856 N/A N/A
Option
Common Stock 856 N/A N/A
Option
Common Stock 723 N/A N/A
Option
Restricted Stock Unit 723 N/A N/A
Option
Restricted Stock Unit 970 N/A N/A
Option
Common Stock 970 N/A N/A
Option
Restricted Stock Unit 767 N/A N/A
Option
Common Stock 767 N/A N/A
Option
Restricted Stock Unit 12,032 N/A N/A
Option
Common Stock 12,032 N/A N/A
Sale
Common Stock 2,830 $211.86 $599,572
Sale
Common Stock 5,627 $209.29 $1,177,697
Sale
Common Stock 11,699 $211.14 $2,470,068
Sale
Common Stock 4,844 $210.21 $1,018,243
Option
Common Stock 11,400 $130.6 $1,488,840
Option
Non-qualified Stock Options 11,600 $146.59 $1,700,444
Option
Common Stock 9,100 $168.49 $1,533,259
Sale
Common Stock 1,500 $254.88 $382,319
Sale
Common Stock 19,338 $254.26 $4,916,861
Sale
Common Stock 11,262 $253.27 $2,852,270
Option
Common Stock 11,600 $146.59 $1,700,444
Option
Restricted Stock Unit 940 N/A N/A
Option
Common Stock 940 N/A N/A
Option
Common Stock 970 N/A N/A
Option
Restricted Stock Unit 970 N/A N/A
Option
Restricted Stock Unit 766 N/A N/A
Option
Common Stock 766 N/A N/A
Option
Restricted Stock Unit 9,024 N/A N/A
Option
Common Stock 9,024 N/A N/A
Option
Restricted Stock Unit 1,720 N/A N/A
Option
Restricted Stock Unit 1,720 N/A N/A
Option
Common Stock 1,720 N/A N/A
Option
Common Stock 970 N/A N/A
Option
Restricted Stock Unit 970 N/A N/A
Option
Restricted Stock Unit 9,024 N/A N/A
Option
Common Stock 9,024 N/A N/A
Option
Restricted Stock Unit 1,720 N/A N/A
Option
Common Stock 1,720 N/A N/A
Option
Restricted Stock Unit 994 N/A N/A
Option
Common Stock 994 N/A N/A
Sale
Common Stock 5,563 $176.75 $983,260
Sale
Common Stock 10,000 $167.63 $1,676,280
Option
Common Stock 780 $146.59 $114,340
Option
Restricted Stock Unit 780 $146.59 $114,340
Option
Common Stock 4,877 N/A N/A
Option
Restricted Stock Unit 4,877 N/A N/A
Option
Common Stock 993 N/A N/A
Option
Restricted Stock Unit 993 N/A N/A
Sale
Common Stock 10,000 $181.28 $1,812,810
Option
Restricted Stock Unit 1,627 N/A N/A
Option
Common Stock 1,627 N/A N/A
Sale
Common Stock 8,400 $167.85 $1,409,940
Option
Common Stock 4,877 N/A N/A
Option
Restricted Stock Unit 4,877 N/A N/A
Option
Restricted Stock Unit 993 N/A N/A
Option
Common Stock 993 N/A N/A
Sale
Common Stock 5,968 $159.46 $951,669
Option
Common Stock 4,050 N/A N/A
Option
Restricted Stock Unit 4,050 N/A N/A
Option
Common Stock 1,627 N/A N/A
Option
Restricted Stock Unit 1,627 N/A N/A
Sale
Common Stock 2,300 $142.47 $327,672
Option
Restricted Stock Unit 1,674 N/A N/A
Option
Common Stock 1,674 N/A N/A
Option
Common Stock 4,876 N/A N/A
Option
Restricted Stock Unit 4,876 N/A N/A
Sale
Common Stock 8,000 $140.38 $1,123,000
Option
Restricted Stock Unit 4,050 N/A N/A
Option
Common Stock 4,050 N/A N/A
Option
Restricted Stock Unit 1,626 N/A N/A
Option
Common Stock 1,626 N/A N/A
Option
Common Stock 1,540 N/A N/A
Option
Restricted Stock Unit 1,540 N/A N/A
Option
Restricted Stock Unit 1,673 N/A N/A
Option
Common Stock 1,673 N/A N/A
Option
Common Stock 4,050 N/A N/A
Option
Restricted Stock Unit 4,050 N/A N/A
Option
Common Stock 1,540 N/A N/A
Option
Restricted Stock Unit 1,540 N/A N/A
Option
Common Stock 1,673 N/A N/A
Option
Restricted Stock Unit 1,673 N/A N/A